Oktay et al. [10] were the first to report the use of a GnRH analog as an oocyte maturation trigger for women with breast cancer undergoing IVF, and found that the number of oocytes retrieved, maturation and fertilization rates, and the number of 2PN embryos were significantly higher than with hCG trigger. Here, GNRH1 is linked to breast carcinoma.